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Abstract
The development of granulomatous inflammation with caseous necrosis is an important but poorly understood
manifestation of tuberculosis in humans and some animal models. In this study we measured the byproducts of oxidative
stress in granulomatous lesions as well as the systemic antioxidant capacity of BCG vaccinated and non-vaccinated guinea
pigs experimentally infected with Mycobacterium tuberculosis. In non-vaccinated guinea pigs, oxidative stress was evident
within 2 weeks of infection as measured by a decrease in the serum total antioxidant capacity and blood glutathione levels
accompanied by an increase in malondialdehyde, a byproduct of lipid peroxidation, within lesions. Despite a decrease in
total and reduced blood glutathione concentrations, there was an increase in lesion glutathione by immunohistochemistry
in response to localized oxidative stress. In addition there was an increase in the expression of the host transcription factor
nuclear erythroid 2 p45-related factor 2 (Nrf2), which regulates several protein and non-proteins antioxidants, including
glutathione. Despite the increase in cytoplasmic expression of Nrf2, immunohistochemical staining revealed a defect in Nrf2
nuclear translocation within granulomatous lesions as well as a decrease in the expression of the Nrf2-regulated antioxidant
protein NQO1. Treating M. tuberculosis–infected guinea pigs with the antioxidant drug N-acetyl cysteine (NAC) partially
restored blood glutathione concentrations and the serum total antioxidant capacity. Treatment with NAC also decreased
spleen bacterial counts, as well as decreased the lung and spleen lesion burden and the severity of lesion necrosis. These
data suggest that the progressive oxidative stress during experimental tuberculosis in guinea pigs is due in part to a defect
in host antioxidant defenses, which, we show here, can be partially restored with antioxidant treatment. These data suggest
that the therapeutic strategies that reduce oxidant-mediated tissue damage may be beneficial as an adjunct therapy in the
treatment and prevention of tuberculosis in humans.
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Introduction
Infections with Mycobacterium tuberculosis, the causative agent of
human tuberculosis, is the most common cause of morbidity and
mortality in patients with HIV/AIDS and is among the leading
causes of death from an infectious agent [1]. The continuing
spread of tuberculosis is evident from the 2009 figures that
estimate the number of newly diagnosed cases of active
tuberculosis worldwide to be 9.4 million [2]. Controlling the
spread of tuberculosis, particularly in developing countries, has
become more challenging by the emergence of multidrug (MDR)
and extensively drug-resistant (XDR) strains of bacilli that are
refractory to first and second line anti-tuberculosis drugs
respectively [3]. While several promising new drugs are in early
clinical trials, no new FDA approved anti-tuberculosis drugs have
been introduced in the last 25 years. Moreover, the effective
treatment of patients for 6 to 9 months with existing drugs is
limited in some patients by the complications associated with toxic
side effects of combination drug therapy. Development of new
anti-tuberculosis drugs or treatment strategies that potentiate the
therapeutic value of currently available drugs is urgently needed
for global tuberculosis control.
The difficulty in effectively treating human tuberculosis is
related to the chronic nature of the disease and the long-term
persistence of drug-tolerant bacilli. There is increasing evidence
from human and animal studies that at least one population of
drug-tolerant bacilli persist within an extracellular microenviron-
ment associated with necrotic and cavitary lesions [4,5]. A better
understanding of the pathogenesis of lesion progression may reveal
novel therapeutic approaches that prevent or specifically target
bacilli that persist within this unique in vivo microenvironment.
Tuberculosis, like other chronic inflammatory diseases, is charac-
terized by the generation of oxygen and nitrogen free radicals. The
generation of free radicals in excess of the antioxidant capacity of
the host leads to cellular and eventually systemic oxidative stress.
Markers of oxidant-mediated tissue damage have been shown to
be elevated in the peripheral circulation of humans with active
tuberculosis [6,7]. Moreover, oxidative stress has been implicated
in the pathogenesis of lung fibrosis and dysfunction in tuberculosis
patients even following antimicrobial therapy [6,8]. Besides an
increase in the byproducts of free radical generation, several
studies have demonstrated that critical antioxidants such as
ascorbic acid and glutathione are depleted in the serum of
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consumptive depletion of protein and non-protein antioxidants
can be further complicated by inadequate dietary replenishment
[9,11].
Besides vaccination and combination antimicrobial therapy, few
interventions have been shown to be effective at reversing or
preventing the progression of active tuberculosis in humans or
animals. Previous studies have shown that in the guinea pig
tuberculosis model, the progression of pulmonary and extra-
pulmonary lesions can be modulated by vaccination with Bacillus
Calmette Guerin (BCG) prior to aerosol infection with virulent M.
tuberculosis [12,13]. The partially protective immune response
primed by BCG vaccination lessens the severity of disease, delays
extra-pulmonary dissemination of bacilli and prevents the
progressive accumulation of free radical generating leukocytes
including macrophages and granulocytes [14].
The collective antioxidant capacity of the host is maintained by
numerous intracellular and circulating protein and non-protein
molecules, which prevent oxidative damage to lipids, proteins, and
nucleic acids. The group of protein antioxidants that detoxify free
radicals through conjugation are referred to as phase II
detoxification enzymes [15]. The induction of phase II enzyme
expression requires binding of specific inducers to the antioxidant
response element (ARE) in the promoter regions of phase II
enzyme genes. Nuclear erythroid 2 p45-related factor 2 (Nrf2), a
redox-sensitive transcription factor, is directly involved in the
transcriptional activation of ARE-driven phase II antioxidant
enzymes. Under normal physiologic conditions, Nrf2 is seques-
tered in the cytoplasm by the binding protein, Kelch-like ECH-
associated protein (Keap1). Under oxidative stress conditions, Nrf2
dissociates from Keap1 allowing translocation of Nrf2 to the
nucleus where it heterodimerizes with small Maf-family proteins
which bind to ARE sequences leading to transcriptional activation
of the various phase II antioxidant enzymes [16].
NAD(P)H dehydrogenase, quinone 1 (NQO1) is one such
protein that prevents free radical formation from quinone
biosynthesis. Glutathione, another Nrf2-regulated antioxidant is
an essential intracellular antioxidant tripeptide that is synthesized
within cells in a two-step, energy dependent reaction. The first and
rate-limiting step in the synthesis of glutathione is catalyzed by
glutamate-cysteine-ligase (GCL; also known as c-glutamylcysteine
synthetase-GCS), which is also transcriptionally regulated by Nrf2
[17,18].
The goals of these studies was to determine what role oxidative
stress has in the progression of experimental tuberculosis in the
guinea pig and whether antioxidant therapy was effective at
lessening the bacterial burden and disease severity. Additionally,
we sought to determine whether a defect in antioxidant defenses,
particularly those regulated by Nrf2 could be restored with the
antioxidant drug N-acetyl cysteine. We also asked whether the
reduction in disease severity in M. tuberculosis infected guinea pigs
that were BCG vaccinated prior to challenge was due to
preservation of antioxidant capacity and Nrf2 function. Our data
suggest that antioxidant therapy may prove beneficial as an
adjunct therapy to reduce disease severity by limiting host tissue
damage. These data suggest that antioxidant therapy could be
used to potentiate the effectiveness of conventional prevention and
treatment strategies in human patients with tuberculosis.
Methods
Aerosol infection of guinea pigs with M. tuberculosis
Mycobacterium tuberculosis H37Rv strain (TMC#102; Trudeau
Institute, Saranac Lake, NY) was grown in Proskauer-Beck liquid
medium containing 0.05% Tween 80 to mid-log phase, aliquoted,
and frozen at 280uC until used for infection. A thawed aliquot of
M. tuberculosis was diluted in sterile water to 10
6 CFU/ml for a
total working stock volume of 20 ml. Guinea pigs (approximately 9
months of age) from each treatment group were aerosolized using
the Madison infection chamber (University of Wisconsin Machine
Shop, Madison, WI) with a starting volume of 15 ml of working
stock [19].
BCG vaccination
Guinea pigs were vaccinated with 1610
4 Mycobacterium bovis
(BCG, strain Pasteur) or mock vaccinated with equal volumes of
saline, intra-dermally 4 weeks prior to aerosol exposure to M.
tuberculosis. M. bovis BCG was grown in Proskauer-Beck similar to
M. tuberculosis and frozen at 280uC until used for vaccination [14].
N-acetyl cysteine treatment
Guinea pigs were treated or mock-treated orally with N-acetyl
cysteine (NAC) (400 mg/kg, Calbiochem, San Diego, CA) from
day 0 to the experimental end-point (day 30 or 60 of infection)
dissolved in 2 ml water containing 20% sucrose or carrier alone.
Euthanasia and sample collection
At intervals of 5, 15, 20, 30 and 60 days of infection, guinea pigs
were euthanized humanely by an overdose (1 ml per 0.75 kg body
weight) of sodium pentobarbital (Sleepaway; Fort Dodge Labora-
tories Inc.) by intraperitoneal injection. Following euthanasia, at
each time point, the left pulmonary lobes were infused in situ and
fixed for 48 hours in 4% paraformaldehyde and thereafter stored
in 70% ethanol. At the time of processing, all tissues were
embedded in paraffin, sectioned at 5 mm, and stained with
hematoxylin and eosin (H&E). At the same time points, bacterial
load of lungs, spleen and peribronchial lymph nodes were
determined by plating respective organ homogenates onto nutrient
7H11 agar plates supplemented with OADC. Colonies are
counted after 21 days of incubation at 37uC [19].
Measurement of serum total antioxidant capacity and
blood glutathione levels
Serum from guinea pigs was assayed for total antioxidant
capacity (Sigma, St. Louis, MO), and whole blood to determine
the oxidized/reduced-glutathione levels and GSH/GSSG ratio
(GSH/GSSG Ratio Assay kit; Calbiochem, San Diego, CA) using
calorimetric assays according to the manufacturer’s protocols.
Immunohistochemistry
Paraffin embedded sections of lung from the experimentally
infected guinea pigs, were collected on positively charged glass
slides, deparaffinized, rehydrated and subjected to antigen
retrieval by incubation in Target Retrieval solution, pH 6.0
(DAKO, Carpentaria, CA) for 25 min at 90uC, followed by a
20 min cooling period at room temperature. The sections were
then treated with 0.3% hydrogen peroxide in water for 15 min to
quench endogenous peroxidase activity. Following a rinse in Tris
buffered saline with 1% Tween-20 (TTBS), the slides were
subjected to two blocking steps: (i) 15 min incubation with
0.15 mM glycine in PBS, and (ii) 30 min incubation with 1%
normal horse serum with a rinse in TTBS in between. The slides
were then incubated with rabbit polyclonal antibody to human
Nrf2, GCS (Santa Cruz Biotechnology, Santa Cruz, CA), MDA,
NQO1 (Abcam, Cambridge, MA) or mouse monoclonal antibody
against glutathione (Virogen, Watertown, MA) or respective
isotype IgG controls at a 1:100 dilution in blocking buffer followed
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incubation with biotinylated goat-anti rabbit-IgG (Vector Labo-
ratories) and visualization of bound antibody by the Avidin-Biotin
system (Vectastain; Vector Laboratories) and diaminobenzidine
substrate (Dako; Carpentaria, CA). The sections were counter-
stained with Meyer’s hematoxylin (Scytek Laboratories; Logan,
Utah), mounted with coverslips, and examined on an Olympus
BX41 light microscope.
The specificity of anti-human antibodies for guinea pig Nrf2
and NQO1was validated by competitive inhibition of binding to
the tissue sections with purified antigens (Nrf2 - Santa Cruz
Biotechnology; NQO1 - Abcam) at a concentration ratio of 1:5
before adding the primary antibody to the respective sections in
lieu of the unblocked primary antibodies. Antibody specificity was
confirmed by the effective blocking of anti–human Nrf2 and
NQO1 antibodies binding to guinea pig tissues with the respective
purified proteins (Figure S1). Photomicrographs were acquired
with an Olympus DP70 camera and the associated computer
software. The reviewer blinded to the treatment groups scored
sections stained by H&E and immunohistochemistry as described
below.
Immunohistochemical scoring
The lung lesions were classified as either primary lesions or
primary lesion free (PLF) lung for immunohistochemical scoring
purposes. Primary lung lesions are the initial foci of inflammation
that develop following aerosol infection of immunologically naı ¨ve
animals and are characterized by central necrosis. Secondary
lesions are the foci of inflammation that develop in the late stage of
infection as a consequence of hematogenous dissemination.
Primary lesion free lung constitutes non-necrotic secondary lesions
and residual normal lung parenchyma [20]. Within these regions
the overall immunohistochemical scoring was determined based
on extent of staining (0-none; 1-less than 25%; 2-26–50%; 3-51–
75%; 4-more than 75%) and staining intensity (0-none: 1-mild; 2-
moderate; 3-marked; 4-extensive). The resultant total overall
scores were converted to a four-point scale. Since the in vivo
function of Nrf2 as a transcription factor is dependent on
cytoplasmic to nuclear translocation, the relative nuclear and
cytoplasmic expression of Nrf2 in lesions and PLF lung was also
scored using the following scale (0-none; 1-less than 25%; 2-26–
50%; 3-51–75%; 4-more than 75%).
Lesion analysis
To evaluate the progression of lesions over time, a histological
grading system was applied, as previously described [21]. The lung
sections were scored based on the following six criteria: (i) percent
of lung affected: 0-no lesions in lung, 1-up to 25% of lung involved,
2-up to 50% of lung involved, 3-up to 75% of lung involved, 4-
above 75% of lung involved. (ii) primary lesions: 0-no primary
lesions present, 1-a single primary lesion, 2-two or more primary
lesions, multi-focal, 3-two or more primary lesions, multifocal to
coalescing, 4-multiple primary lesions, coalescing and extensive.
(iii) secondary lesions: 0-no secondary lesions present, 1-up to 25%
of lung involved, 2-up to 50% of lung involved, 3-up to 75% of
lung involved, 4-above 75% of lung involved. Necrosis (iv),
mineralization (v) and fibrosis (vi) are scored based on severity as
follows: 0-none, 1-minimal, 2-mild, 3-moderate, 4-marked. The
subcategory scores were added for the final total score for each
organ (Range: 0–24). The spleen lesions were scored based on four
categories; (i) percentage involvement (same scale as lungs), (ii)
degree of necrosis, (iii) fibrosis and (iv) mineralization. The total
spleen score range is 0 to 16.
Statistical analysis
The statistical differences of lesion/necrosis scores or immuno-
staining scores among different time points were analyzed using
non-parametric Kruskal-Wallis test. The specific statistical differ-
ences between two individual group scores were analyzed using
non-parametric Mann-Whitney test. The statistical differences
between numbers of bacilli, antioxidant levels, total glutathione
levels and GSH/GSSG ratio were analyzed using two-way
ANOVA and non-paired student t test. Statistical analysis of
correlation was performed for the groups discussed in the results.
All of the statistical tests were done using the Prism software
(version 4.03, Graph Pad, La Jolla, CA).
Results
Presence of malondialdehyde (MDA) in infected guinea
pig lungs
MDA is one of the major aldehyde byproducts of lipid
peroxidation that accumulate in the peripheral circulation and
in tissues under oxidative stress conditions. During the generation
of reactive oxygen species (ROS), MDA forms numerous protein
adducts that can be specifically detected by immunohistochemis-
try. There was a statistically significant (p,0.05) increase in MDA
expression in M. tuberculosis-infected guinea pig lungs beginning on
day 20 of infection that progressed between days 30 and 60
(Figure 1A). Lungs from M. tuberculosis-infected guinea pigs on day
5 of infection and non-infected animals showed minimal or no
immunostaining for MDA. The accumulation of MDA showed a
strong positive correlation with pulmonary lesion progression
(r=0.97 and p#0.005; lesion scores not shown). The progressive
increase in MDA expression was predominantly within the
primary granulomas (Figure 1B). Overall immunostaining scores
represented the sum total scores for both primary lesions and
primary lesion-free (PLF) lung. The staining was comparatively
unchanged within the PLF lung at different time points
(Figure 1C). The cell types that showed the most intense MDA
staining included macrophages, vascular endothelial cells
(Figures 1D and E) and granulocytes.
Serum total antioxidant capacity
The total antioxidant capacity of the serum was determined
using an assay based on the ability of serum antioxidants to
quench radical cation (soluble chromogen) production when ferryl
myoglobin reacts with an enzyme substrate. Total antioxidant
capacity of the serum samples collected from mock-vaccinated and
BCG- vaccinated-M. tuberculosis-infected guinea pigs on days 15,
30, 60 and 90 of infection are illustrated in Figure 2. The serum
total antioxidant capacity in M. tuberculosis-infected guinea pigs
mock-vaccinated with saline ranged from undetectable levels as
early as 15 days of infection to 0.0660.06 mM, whereas the total
antioxidant levels in the BCG-vaccinated, M. tuberculosis infected
animals were four to five fold higher ranging from 0.2060.06 mM
to 0.2760.04 mM. The antioxidant capacity of naı ¨ve un-infected
guinea pigs was similar to that of BCG vaccinated guinea pig
values being 0.21160.042 mM (n=7). There was no statistical
difference in antioxidant levels between uninfected naive guinea
pigs and BCG vaccinated infected animals and BCG vaccination
normalizes systemic antioxidant levels to uninfected values.
Whole blood glutathione levels
Glutathione, a thiol tripeptide antioxidant is among the most
critical antioxidants and is present in the reduced (GSH) and
oxidized form (GSSG) in all mammalian cells [22]. M. tuberculosis
infection in guinea pigs resulted in a significant reduction in the
Guinea Pig Defective Antioxidant Responses
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26254reduced-glutathione levels in whole blood on days 30 and 60 after
infection compared to the naive animals (Figure 3A). The
oxidized-glutathione levels did not change significantly throughout
the course of infection (Figure 3A). However, there was a
progressive decrease in the blood antioxidant capacity as expressed
as a ratio of reduced- and oxidized-glutathione (GSH/GSSG)
(Figure 3B).
Glutathione expression in lung lesions
Tissue glutathione expression was estimated in the lungs from
M. tuberculosis-infected guinea pigs by immunohistochemistry.
There was a statistically significant (p,0.05) increase in expression
of glutathione in lung lesions from M. tuberculosis-infected guinea
pig on days 30 and 60 (Figure 4A). Similar to MDA, the increase
in glutathione immunostaining occurred predominantly within the
primary granulomas (Figure 4B) and less so in the PLF lung across
the different time points (Figure 4C). The pattern of lung cell
glutathione expression was similar to that of MDA (Figures 4D
and E).
Nrf2 expression in lungs
Nrf2 is a crucial redox sensitive transcription factor that controls
expression of several important antioxidant enzymes including
NQO1 and GCS. There was an overall increase in Nrf2
immunostaining in M. tuberculosis-infected guinea pig lung lesions
as the infection progressed (Figures 5A through 5E). Nrf2 staining
was predominant within the primary granulomas on days 30 and
60 (Figures 5C and 5D). Closer examination using higher
magnification revealed roughly equal cytoplasmic and nuclear
expression of Nrf2 throughout the lungs early in the infection (days
5 and 15) and in less-affected PLF regions of lungs late in the
infection (days 30 and 60) (Figures 5G and 5H). In contrast, within
Figure 1. There is increased malondialdehyde accumulation in the lungs of M. tuberculosis infected guinea pigs. The graphs A, B and C
represent MDA immunostaining scores within overall, primary granuloma and primary lesion free (PLF) lung areas respectively at different time points
of Mtb H37Rv infection (median+range, n=5). The stars denote statistically significant increase compared to the naive animals (*=p,0.05 and
**=p,0.01). The photomicrographs D and E represent immunostaining of MDA in Mtb-infected guinea pig lungs from day 30 and day 60 of infection
respectively (arrowheads show intracellular staining within macrophages and vascular endothelial cells).
doi:10.1371/journal.pone.0026254.g001
Figure 2. M. tuberculosis infection of guinea pigs results in
decreased serum antioxidant capacity. The graph illustrates
systemic mean (6 SD) total antioxidant levels in serum of Mtb-infected
guinea pigs that are either saline vaccinated (control) or BCG vaccinated
(n=5). The mean total antioxidant level in serum of naı ¨ve guinea pigs is
0.21160.042 mM (n=5).
doi:10.1371/journal.pone.0026254.g002
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sion of Nrf2 was predominantly cytoplasmic with minimal nuclear
staining (p,0.05) as early as day 20, which was pronounced by
day 30 and 60 (Figures 5F and 5I).
A similar lack of nuclear expression of Nrf2 was seen in guinea
pig bronchoalveolar lavage (BAL) cells at 4, 24, 48 and 72 hrs after
in vitro infection with M. tuberculosis (Figure S2). Only a weak
cytoplasmic and no nuclear staining of Nrf2 was evident starting as
early as 4 hours after infection.
Nrf2-regulated antioxidant protein expression
The lack of Nrf2 nuclear translocation suggesting a defect in
Nrf2-mediated antioxidant defenses was confirmed by evaluating
the expression of the Nrf2-regulated expression of NQO1 and
Figure 3. Total and reduced blood glutathione levels are decreased during M. tuberculosis infection in guinea pigs. The graph A
denotes the systemic levels of reduced- and oxidized-glutathione (GSH and GSSG respectively) in the blood of naive and Mtb-infected guinea pigs on
days 30 and 60 after the infection. The graph B illustrates the ratio between reduced- and oxidized-glutathione in blood from the same animals. Stars
represent statistically significant decrease compared to the naive animals (*=p,0.05, **=p,0.01 and ***=p,0.001).
doi:10.1371/journal.pone.0026254.g003
Figure 4. Glutathione expression is increased in lung lesions of M. tuberculosis-infected guinea pigs. The graphs A, B and C represent
glutathione immunostaining scores (median+range, n=5) within overall, primary granuloma and primary lesion free (PLF) lung areas respectively at
different time points (*=p,0.05 and **=p,0.01 when compared to the naive animals). Figures D and E illustrate predominant glutathione staining
in the primary granulomas (arrows) with necrotic core on day 30 (non-mineralized core) and on day 60 (mineralized core). Inserts show the
intracellular staining within the macrophages (2006, arrowheads).
doi:10.1371/journal.pone.0026254.g004
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and D represent Nrf2 immunostaining within infected lungs from day 0, 20, 30 and 60 respectively. Arrowheads (in A&B) show intracellular staining
within macrophages. Arrows (in C & D) show primary granulomas with necrotic core demonstrating Nrf2 staining. The graph E represents Nrf2 overall
lung immunostaining scores at different time points of infection. The bars represent median values (+range) for each group (n=5). The stars denote
statistically significant increase compared to the naive animals (*=p,0.05 and **=p,0.01). The graphs F and G represent median cytoplasmic and
nuclear staining scores (+range) at different time points within primary granuloma and PLF lung areas respectively. The photomicrographs H and I
represent immunostaining of Nrf2 in PLF lung (arrows show both intracytoplasmic and nuclear staining within macrophages) and primary granuloma
(arrowhead shows predominantly intracytoplasmic but no nuclear staining of Nrf2 in macrophages) of a same animal on day 30.
doi:10.1371/journal.pone.0026254.g005
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(Figure 6A) which inversely correlated with increased Nrf2
cytoplasmic expression over time (r=20.96). Throughout the
infection, immunostaining of NQO1 was localized within the PLF
regions of the lungs where NQO1 expression overlapped with the
high Nrf2 expression levels (Figures 6C). The primary granulomas
on day 20, 30 and 60 showed minimal NQO1 expression
(Figures 6B and 6E). Airway epithelium (Figure 6D), vascular
endothelium and alveolar macrophages consistently expressed
NQO1 in the early stages of infection (days 5, 15 and 20). As the
disease progressed, only minimal immunostaining of these cells
was seen (Figure 6E).
The expression of GCS was less pronounced than NQO1 in the
lungs of infected guinea pigs compared to non-infected in naı ¨ve
guinea pig lungs. However, no difference in GCS immunostaining
was seen between days 5 and 60. Also, no significant difference in
expression levels of GCS was observed between primary
granuloma and PLF lungs (data not shown).
Effect of NAC treatment of M. tuberculosis infected
guinea pigs
As NAC has been shown to induce Nrf2-mediated antioxidant
defenses, M. tuberculosis-infected guinea pigs were treated with
NAC in an attempt to reverse the adverse effects of oxidative stress
[23]. The daily administration of NAC resulted in nearly one log
reduction in the number of bacilli in the spleen on day 30 which
correlated with a significant decrease in lesion burden (Figure 7A
and 7C) which was less but still statistically significant by day 60
(Figures 7B). No significant differences in the numbers of bacilli
were observed between control and NAC-treated groups on day
30 and 60 in lungs and peribronchial lymph node (PBLN)
(Figures 7A and 7B).
A statistically significant reduction in overall spleen lesion scores
(p,0.01) in NAC-treated animals was observed on day 30 of
infection (Figure 7C). Moreover, statistically significant reduction
in lesion necrosis scores was seen in NAC-treated guinea pig lungs
(p,0.05) and spleen (p,0.01) compared to the control groups on
day 30 of the infection (Figures 7D). The decrease in lesion burden
and extent of necrosis in the lungs and spleen of NAC-treated
animals are depicted in Figure 8 (A, B, E & F-lungs; C, D, G & H-
spleen).
There was a statistically significant increase in nuclear
expression of Nrf2 (p,0.05) within lung primary granulomas on
days 30 and 60 in the NAC-treated group compared to mock-
treated control groups (Figures 9A and 9B). Moreover there was a
statistically significant increase in NQO1 expression (p,0.05)
within primary granulomas on days 30 and 60 in NAC-treated
guinea pig compared to the mock-treated control groups
(Figures 9C).
An increase in whole blood reduced-glutathione (GSH) was seen
in NAC-treated animals compared to the mock-treated control
group on day 60 of infection (p,0.05). No significant differences
were noted in GSH levels on day 30 of the infection and in
oxidized-glutathione (GSSG) levels between the control and NAC-
treated animals throughout the course of infection. Similarly
increases in the GSH/GSSG ratio was not statistically significant
in NAC-treated animals compared to the control group on day 30
and but increased significantly by day 60 of infection (p,0.005) in
Figure 6. Nrf2-regulated antioxidant protein NQO1 expression is decreased in lung lesions from M. tuberculosis infected guinea
pigs. The graphs A, B and C represent NQO1 immunostaining scores within overall, primary granulomas and primary lesion free (PLF) lung areas
respectively at different time points. The bars represent median values (+range) for each group (n=5). The photomicrographs D and E represent
immunostaining of NQO1 in M. tuberculosis -infected guinea pig lungs on day 5 (arrow shows strong immunoreactivity within airway epithelial cells)
and day 30 (arrow points to a granuloma with no immunoreactivity) respectively.
doi:10.1371/journal.pone.0026254.g006
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severity. The graphs A and B represent mean numbers of bacilli in different organs from control and NAC treated guinea pigs on day 30 and 60
respectively (mean+SD, n=5). The graphs C and D represent overall lesion and necrosis scores (median+range) respectively of lungs and spleen from
control and NAC treated animals on days 30 and 60 (n=5). Statistically significant change, if present, is indicated with stars (**=p,0.01).
doi:10.1371/journal.pone.0026254.g007
Guinea Pig Defective Antioxidant Responses
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26254Figure 8. Treatment of M. tuberculosis infected guinea pigs with NAC reduces pulmonary and extra-pulmonary granuloma necrosis.
The photomicrographs A, B, C and D represent lesion pathology in the lungs (A & B) and spleen (C & D) on day 30 in control (A & C) and NAC (B & D)
treated animals. The arrows in A and C (controls) show a large core of necrosis and the arrowheads in B and C (NAC treated) point to granulomas with
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of the serum was statistically significant increase (p,0.05) in NAC-
treated guinea pigs compared to mock-treated controls by day 60
of infection (Figure 9G).
Discussion
The clinical manifestations of tuberculosis in humans and
animals are directly proportional to the severity and extent of
minimal to no necrosis. The photomicrographs E, F, G and H represent the lesion burden in the lungs (E & F) and spleen (G & H) on day 60 in control (E
& G) and NAC (F & H) treated animals. The arrows in E and G (controls) show a large area of necrosis and the arrowheads in F and H (NAC treated)
show the granulomas with smaller area of necrosis.
doi:10.1371/journal.pone.0026254.g008
Figure 9. NAC treatment of M. tuberculosis infected guinea pig partially restores antioxidant capacity. The graphs A and B represent the
cytoplasmic and nuclear Nrf2 staining scores within primary granulomas of animals treated with control or NAC on days 30 and 60 respectively
(median+range, n=5). The graph C represents NQO1 staining within primary granulomas of animals treated with control or NAC on days 30 and 60
(median+range, n=5). The graphs D and E represent reduced- and oxidized-glutathione levels (GSH and GSSG) in control and NAC treated animals on
days 30 and 60 respectively (mean+SD, n=5). The graph F represents GSH/GSSG ratio in the blood of control or NAC-treated guinea pigs on days 30
and 60. The graph G represents the systemic total antioxidant levels of serum from control and NAC treated guinea pigs on days 30 and 60
(mean+SD, n=5). The stars denote statistically significant increase in NAC-treated animals compared to the control animals (*=p,0.05 and
**=p,0.01).
doi:10.1371/journal.pone.0026254.g009
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stages of M. tuberculosis infection in humans lesions are composed
primarily of macrophages and granulocytes with fewer lympho-
cytes [4]. Similar cell phenotypes are seen in the early stages of
experimental M. tuberculosis infection in guinea pigs. The
significance of these findings is that like in other species,
macrophages and granulocytes are among the most potent
generators of oxygen free radicals during an inflammatory
response [14,25,26]. Previously, we showed that the development
of lesion necrosis correlated with an increased influx of
macrophages and granulocytes in the lung and that could be
prevented in guinea pigs that were vaccinated with BCG prior to
M. tuberculosis challenge [14,25]. Besides co-localizing to sites of
necrosis, we showed that these inflammatory cells released their
cytoplasmic contents resulting in extracellular accumulation of
iron and copper, both of which catalyze free radical generation
[25,27].
Our primary objective in this study was to establish the presence
of oxidative stress conditions during experimental tuberculosis in
guinea pigs and to determine whether antioxidant therapy could
reverse the adverse effects of progressive inflammation in this
model. Since reactive oxygen and nitrogen species have extremely
short half-lives and are difficult to measure directly, we evaluated
the byproducts of free radical generation in vivo and measured the
serum and tissue antioxidant capacity of M. tuberculosis infected
guinea pigs over time. The oxidative stress marker, MDA,
increased in lung lesions as M. tuberculosis infection in guinea pigs
progressed. Interestingly besides macrophages and granulocytes,
vascular endothelial cells associated with lesions also showed
prominent MDA staining as the infection progressed. The
significance of this finding is that free radical-mediated endothelial
damage may contribute to the pathogenesis of lesion necrosis by
promoting microvascular thrombosis leading to lesion ischemia
[28].
The serum total antioxidant capacity was significantly depleted
in M. tuberculosis infected guinea pigs as early as 15 days of
infection. These data confirmed that oxidative stress conditions
occur in the early stages of infection and is established systemically
even before lesions are advanced. BCG vaccination prior to
aerosol challenge maintained the serum antioxidant capacity in M.
tuberculosis infected guinea pigs near the levels of un-infected
control animals. However, the serum antioxidant capacity
decreased even in BCG-vaccinated animals by day 60 of the
infection is consistent with the loss of immune protection conferred
by vaccination in the chronic stages of disease [14].
As glutathione is among the most important intracellular and
extracellular antioxidants, we compared the total, reduced- and
oxidized-glutathione levels in whole blood of M. tuberculosis-
infected guinea pigs. Reduced-glutathione (GSH) levels were
markedly decreased as the infection progressed which was
reflected by a significant decrease in the GSH/GSSG ratio. These
data are consistent with the depletion of total antioxidant capacity,
which is due in part to total, and more specifically reduced blood
glutathione levels. Despite the decrease in glutathione levels, an
overall increase in total glutathione expression in lung lesions was
indicative of the host response to oxidative stress as a consequence
of M. tuberculosis infection. Since the anti-glutathione antibody used
in this study does not distinguish between the reduced and
oxidized forms, immunohistochemistry cannot be used to evaluate
the relative antioxidant capacity due to glutathione within lesions
using this method. The MDA expression in lung lesions combined
with the decrease in serum total antioxidant capacity, and GSH/
GSSG ratio, confirms the presence of oxidative stress conditions in
experimental tuberculosis in the guinea pigs similar to what is seen
in the naturally occurring human disease [6,8].
Our second objective was to identify potential mechanisms to
explain the failure to maintain adequate antioxidant capacity in
M. tuberculosis infected guinea pigs. Since the redox sensitive
transcription factor Nrf2 regulates the expression of several
important antioxidant proteins and nuclear translocation is
necessary for normal Nrf2 function, we evaluated the relative
nuclear to cytoplasmic expression in lung lesions and primary
lesion free lung using immunohistochemistry. Overall Nrf2
expression increased in primary lesions as the infection progressed
in non-treated and non-vaccinated animals. This increased
expression correlated significantly with the progression of disease
that was reflected in the increased lesion pathology scores. Despite
the increase in cytoplasmic Nrf2 expression, there was a significant
lack of nuclear staining in primary lesions compared to naı ¨ve or
non-affected regions of lung parenchyma. The lack of nuclear
expression of Nrf2 within primary granulomas also correlated with
the lack of expression of the Nrf2-regulated antioxidant protein
NQO1 within the primary granulomas. NQO1 expression was
limited to the areas that had Nrf2 nuclear expression (non-affected
lung regions), and was decreased within primary granulomas that
lacked nuclear expression. Another known Nrf2-regulated enzyme
GCS did not follow a similar pattern. In fact, GCS had moderately
high level of expression throughout the course of the infection with
minimal change in expression levels between different time points
and between primary granulomas and primary lesion free lung
parenchyma. This is consistent with previous studies that showed
that GCS expression is also regulated by Nrf2-independent
mechanisms [29,30].
A similar lack of nuclear translocation of Nrf2 has been
previously reported in an in-vitro model of cigarette smoke-
mediated oxidative stress. In that study, treatment with an Nrf2-
inducing drug, resveratrol, induced nuclear translocation of Nrf2
and subsequent quenching of cigarette smoke generated free
radical release [31]. The cytoskeleton serves as scaffolding to bind
and regulate nuclear translocation of Nrf2 within the cell
cytoplasm [32]. One possible explanation is that M. tuberculosis
infection may interfere with this Nrf2 regulatory mechanism
directly by altering actin polymerization [33,34] or indirectly by
promoting oxidation of intra-cytoplasmic proteins during infection
[35].
Since BCG vaccination prevented the reduction in systemic
antioxidant capacity in early stages of the infection, we determined
whether the beneficial effects of BCG vaccination prevented the a
defect in Nrf2 nuclear expression. However, there was no
difference between vaccinated and unvaccinated guinea pigs in
the extent of NQO1 and nuclear Nrf2 expression (Figure S3).
These data suggest that despite the ability to maintain systemic
antioxidant capacity, BCG vaccination fails to prevent the
localized defects in antioxidant defenses and thus only delays the
manifestations of progressive lung and disseminated disease that
ultimately results in death in the guinea pig model [14].
Therapeutic intervention with NAC aimed at reversing
defective Nrf2-mediated antioxidant defenses resulted in a
decrease in pulmonary and extra-pulmonary lesion and bacterial
burden and reduced the severity of lesion necrosis. The improved
outcome in NAC-treated animals was associated with increased
Nrf2 nuclear staining, granuloma NQO1 expression, increased
glutathione (reduced form) levels and improved serum antioxidant
capacity compared to the mock-treated controls. NAC serves as an
additional source of the amino acid cysteine that is needed for
glutathione synthesis but also activates Nrf2 expression, both of
which likely contribute to combating oxidative stress during M.
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at delaying the dissemination of bacilli to the spleen suggesting a
protective effect on lung vasculature. This response is consistent
with the role lesion necrosis and the loss of vascular integrity has in
the pathogenesis of extra-pulmonary dissemination of bacilli.
In summary, we have provided evidence that oxidative stress
conditions exist in the guinea pig model of tuberculosis similar to
what is seen in humans. We also show that systemic and tissue
oxidative stress is progressive and correlates with the loss of Nrf2-
mediated antioxidant defense mechanisms. Considering the
importance of lung lesion progression and the extra-pulmonary
dissemination of bacilli in tuberculosis pathogenesis, treating with
antioxidant drugs like NAC could be beneficial as an adjunct to
conventional anti-tuberculosis drug therapy. An added benefit of
antioxidant treatment of patients with tuberculosis is the reduction
of the toxic side effects of anti-tuberculosis drug therapy which as
also be shown to be mediated oxygen free radical generation in the
liver [37].
Supporting Information
Figure S1 Negative control staining for antibodies used
in this study. The photomicrographs A, B, C and D represent
MDA, glutathione, Nrf2 and NQO1 immunostaining respectively
in lungs of M. tuberculosis-infected animals either after the addition
of antigens in excess to the primary antibody prior to staining for
Nrf2 and or after primary antibody being replaced with species-
specific polyclonal IgG for glutathione and MDA. As expected no
immunostaining in detected in lungs for all four antibodies.
(TIF)
Figure S2 Nrf2 immunoflourescence in BAL cells after
M. tuberculosis infection. The panels above show Nrf2
protein levels at (A) freshly collected non-cultured; (B) 24 hrs after
culture (0 hrs after infection with H37Rv); (C, D, E and F) 4, 24,
48 and 72 hrs after infection with M. tuberculosis. Even though both
nuclear and cytoplasmic expression of Nrf2 is detected at 24 hrs
after activation with phorbol 12-myristate-13-acetate (PMA), only
a weak cytoplasmic and no nuclear staining of Nrf2 is noted
starting as early as 4 hours after initial infection.
(TIF)
Figure S3 BCG vaccination fails to alter defective Nrf2
response in infected animals. The graphs A, B and C
represent Nrf2 overall, Nrf2 primary granuloma and NQO1
overall lung immunostaining scores respectively at different time
points in BCG-vaccinated M. tuberculosis-infected animals. The
bars represent median values for each group (n=5).
(TIF)
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